Proteins for functional studies


Antigens for antibody production


Therapeutic proteins and antibody fragments for proof of concept studies


High throughput screening of recombinant proteins


Recombinant proteins for diagnostics


Process development to optimize the production in order to increase yield, purification process development and batch production of recombinant biologics (protein/plasmid DNA).


During the research and development phase and production of protein based therapeutics, finding the optimal conditions for protein production is often a time-consuming and labor-intensive process. With these challenges in mind, a new platform has been designed and developed to produce recombinant biologics in a 

rapid, reliable, and repeatable model at minimal cost.

Using a solid media-based E. coli platform, Caltech Life Science offers CRO and CMO services at a very attractive price.